Pall Biotech Integrated Solutions for Gene Therapy

 

Pall have technologies that enable production of viral vectors on a production scale in a relatively small footprint. The statement holds true for both AAV and lent virus. The talk will cover both upstream and downstream technologies starting with seed train all the way through to the final formulation and filling step. With regards to bioreactors we will cover both adherent cell and suspension cell capabilities and projected future movements in the field. We will touch on process development services (PDS) where Pall are able to bring all of their expertise in continuous intensified process development to shorten the path to market for gene therapies.

Speaker

rick morris

Rick Morris, Ph.D.

 

Senior Vice President, R&D

Palll Biotech



Dr. Rick Morris has held many senior-level positions within both the Life Sciences and Industrial lines of business at Pall Corporation, gaining experience in the biopharmaceutical, medical, food & beverage and laboratory markets during his 30-year tenure. In September 2017, he was appointed as a senior vice president of R&D for Pall Biotech, which combines both single use technologies and biopharmaceutical groups, with a specific focus on the rapidly growing field of continuous bioprocessing. In this role Dr. Morris leads internal and external research and development projects on a global basis. He is based in Westborough, MA, USA and has R&D teams in the USA, UK and Belgium.

Pall Biotech Integrated Solutions for Gene Therapy

icon image

Scale Up And Risk Mitigation Of Therapeutic Viral Vectors For Gene Therapy

Register to learn more about scale up and risk mitigation of viral vectors for GT.

더 Biotech 웨비나
Our webinars keep you informed on the latest products and technologies, current industry topics, the latest trends and a range of innovations and solutions to help continuously improve your processes.
December 2020
Servicios de Validación de Filtración y Single Use Technology

Biotech | Pall Corporation 웨비나 시리즈

¡Todo sobre los ensayos de validaciones para cumplir con los máximos estándares regulatorios!

Hablaremos sobre puntos cruciales de los servicios de validación, incluyendo:

1. Necesidad de validación

2. Cómo se realizan los ensayos de validación

3. Análisis de riesgo: re uso de filtros y toma de decisión en ensayos a realizar

4. Servicio de Validación Pall: documentación requerida para iniciar una cotización

¡No pierdas esta segunda oportunidad!

시청